These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22879944)

  • 21. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
    Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
    World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.
    Petrova NV; Kashirskaya NY; Saydaeva DK; Polyakov AV; Adyan TA; Simonova OI; Gorinova YV; Kondratyeva EI; Sherman VD; Novoselova OG; Vasilyeva TA; Marakhonov AV; Macek M; Ginter EK; Zinchenko RA
    BMC Med Genet; 2019 Mar; 20(1):44. PubMed ID: 30898088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.
    Fredj SH; Messaoud T; Templin C; des Georges M; Fattoum S; Claustres M
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):577-81. PubMed ID: 19715466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability.
    Meng X; Clews J; Kargas V; Wang X; Ford RC
    Cell Mol Life Sci; 2017 Jan; 74(1):23-38. PubMed ID: 27734094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
    Chen JH; Cai Z; Sheppard DN
    J Biol Chem; 2009 Dec; 284(51):35495-506. PubMed ID: 19837660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do common in silico tools predict the clinical consequences of amino-acid substitutions in the CFTR gene?
    Dorfman R; Nalpathamkalam T; Taylor C; Gonska T; Keenan K; Yuan XW; Corey M; Tsui LC; Zielenski J; Durie P
    Clin Genet; 2010 May; 77(5):464-73. PubMed ID: 20059485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
    Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.
    Cormet-Boyaka E; Jablonsky M; Naren AP; Jackson PL; Muccio DD; Kirk KL
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8221-6. PubMed ID: 15141088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CFTR gene mutation spectrum among 735 Iranian patients with cystic fibrosis: A comprehensive systematic review.
    Alibakhshi R; Mohammadi A; Khamooshian S; Kazeminia M; Moradi K
    Pediatr Pulmonol; 2021 Dec; 56(12):3644-3656. PubMed ID: 34525262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of CFTR transmembrane span integration by disease-causing mutations.
    Patrick AE; Karamyshev AL; Millen L; Thomas PJ
    Mol Biol Cell; 2011 Dec; 22(23):4461-71. PubMed ID: 21998193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation.
    Chen X; Zhu S; Zhenin M; Xu W; Bose SJ; Wong MP; Leung GPH; Senderowitz H; Chen JH
    FASEB J; 2019 Apr; 33(4):5126-5142. PubMed ID: 30668920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity.
    Seibert FS; Linsdell P; Loo TW; Hanrahan JW; Riordan JR; Clarke DM
    J Biol Chem; 1996 Nov; 271(44):27493-9. PubMed ID: 8910333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator.
    Zhang Z; Chen J
    Cell; 2016 Dec; 167(6):1586-1597.e9. PubMed ID: 27912062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the Disease-Liability of Mutations in CFTR.
    Ferec C; Cutting GR
    Cold Spring Harb Perspect Med; 2012 Dec; 2(12):a009480. PubMed ID: 23209179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
    Rubenstein RC
    Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.